Lineage Cell Therapeutics, Inc. Construction in Progress, Gross
Lineage Cell Therapeutics, Inc. (LCTX) had Construction in Progress, Gross of $1.27 million as of 2018-12-31, per its 10-K filed 2020-03-12.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, before Accumulated Depreciation, Depletion, and Amortization
us-gaap:ConstructionInProgressGross · last filed 2020-03-12
- 2018-12-31: Construction in Progress, Gross $1.27M.
- 2016-09-30: Construction in Progress, Gross $1.60M.
- 2016-06-30: Construction in Progress, Gross $1.60M.
- 2015-09-30: Construction in Progress, Gross $4.60M.
| Period end | Construction in Progress, Gross | Construction in Progress, Gross as first filed |
|---|---|---|
| 2018-12-31 | $1.27M 10-K · filed 2020-03-12 | |
| 2016-09-30 | $1.60M 10-Q · filed 2016-11-04 | |
| 2016-06-30 | $1.60M 10-Q · filed 2016-08-09 | |
| 2015-09-30 | $4.60M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $3.42M 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $606.64K 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $406.00K 10-Q · filed 2015-11-09 | $405.73K 10-K · filed 2015-03-11 |
| 2013-12-31 | $0.00 10-K · filed 2015-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |